Aberrant MicroRNA Expression in Patients With Endometrial Cancer-Reference-Cited by-同舟云学术

Aberrant MicroRNA Expression in Patients With Endometrial Cancer

Published:2017-03 Issue:3 Volume:27 Page:459-466
ISSN:1048-891X
Container-title:International Journal of Gynecological Cancer
language:en
Short-container-title:International Journal of Gynecological Cancer

Author:

Montagnana Martina,Benati Marco,Danese Elisa,Giudici Silvia,Perfranceschi Melissa,Ruzzenenete Orazio,Salvagno Gian Luca,Bassi Antonella,Gelati Matteo,Paviati Elisa,Guidi Gian Cesare,Franchi Massimo,Lippi Giuseppe

Publisher

BMJ

Subject

Obstetrics and Gynaecology,Oncology

Reference35 articles.

1. Worldwide burden of gynaecological cancer: The size of the problem

2. Cancer statistics, 2014

3. Update on Prognostic Markers for Endometrial Cancer

4. The utility of serum human epididymis protein 4 (HE4) in patients with a pelvic mass

5. The ROMA (Risk of Ovarian Malignancy Algorithm) for estimating the risk of epithelial ovarian cancer in women presenting with pelvic mass: is it really useful?

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. microRNA profile of endometrial cancer from Indian patients-identification of potential biomarkers for prognosis;Biochemistry and Biophysics Reports;2024-09

2. Comparative Assessment of miR-185-5p and miR-191-5p Expression: From Normal Endometrium to High-Grade Endometrial Cancer;Cells;2024-06-25

3. MicroRNA Expression in Endometrial Cancer: Current Knowledge and Therapeutic Implications;Medicina;2024-03-15

4. Diverse roles of miRNAs in breast cancer and gynecologic cancers;MicroRNA in Human Infectious Diseases;2024

5. Exploring the role of non-coding RNA mediated regulation of signaling pathways in endometrial cancer;Advances in Cancer Biology - Metastasis;2023-12